← Back to Clinical Trials
Recruiting NCT06676345

NCT06676345 Mechanical Complications of Acute Myocardial Infarction: a Multicenter Prospective Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06676345
Status Recruiting
Phase
Sponsor Maastricht University Medical Center
Condition Ventricular Septal Defect
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2025-01-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Surgical treatmentPercutaneous treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 800 participants in total. It began in 2025-01-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In 2019, the international study titled "CAUTION Study - 1" (MeChanical complicAtions of acUte myocardial infarcTion: an InternatiOnal multiceNter cohort study), a retrospective multicenter study, was launched and registered on ClinicalTrials.gov (Identifier: NCT03848429). This study highlighted the outcomes of surgical treatment of post-infarction mechanical complications in patients operated between 2000 and 2019. Several scientific publications have resulted from this registry, which involved 27 international centers and recruited about 800 patients. However, retrospective studies are inherently limited by factors such as selection bias and a high number of missing data, affecting data interpretation and consistency of results. Moreover, most registries report only data about surgical patients or, in rare situations, about patients treated percutaneously. To overcome these limitations, a prospective study has been designed to collect more precise and focused data and achieve results that better reflect the current clinical practice, including all the patients diagnosed with post-infarction mechanical complications, independently from the treatment assigned. "CAUTION Study - 2" is, therefore, a prospective, multicenter cohort study with the primary aim of analyzing the outcomes of surgical, percutaneous and conservative treatment of post-infarction mechanical complications in the contemporary era.

Eligibility Criteria

Inclusion Criteria: * all the patients diagnosed with post-infarction mechanical complications, independently from the treatment assigned Exclusion Criteria: * patients with cardiac rupture not acute myocardial infarction related

Contact & Investigator

Central Contact

Matteo Matteucci, MD, PhD

✉ matteomatteucci87@gmail.com

📞 +39.3493556001

Frequently Asked Questions

Who can join the NCT06676345 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Ventricular Septal Defect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06676345 currently recruiting?

Yes, NCT06676345 is actively recruiting participants. Contact the research team at matteomatteucci87@gmail.com for enrollment information.

Where is the NCT06676345 trial being conducted?

This trial is being conducted at Varese, Italy.

Who is sponsoring the NCT06676345 clinical trial?

NCT06676345 is sponsored by Maastricht University Medical Center. The trial plans to enroll 800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology